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Summary: This study was undertaken in dogs to investigate the effects 
of nicardipine (NCR)- and prostaglandin E1 (PGE1)- induced 
hypotension on left ventricular myocardial function, and on coronary 
hemodynamics in the presence of a partially obstructed left coronary 
artery. A stenosis of left circumflex coronary artery (LCX) was 
induced to reduce LCX blood flow by 20%. Mean arterial pressure 
(MAP) was lowered by infusion of NCR or PGE1 to 80% and 60% of 
the control. Heart rate, cardiac index, left ventricular dp/dt max, 
myocardial oxygen extraction ratio, inner/outer blood flow ratio and 
myocardial lactate extraction ratio showed no significant change at 
either 80%- or 60%-MAP during infusion of either drug. PGE1 
-induced hypotension reduced left ventricular end-diastolic pressure 
at both 80%- and 60%-MAP. The results indicate that the moderate 
hypotension induced by NCR or PGE1 does not exert either 
myocardial depression or adverse effects on the myocardial oxygen 
supply-demand relationship in the presence of a critical coronary 
stenosis.
Introduction 
Deliberate hypotension is an anesthetic technique to de-
crease blood loss during surgery and to provide a dry field 
for the surgeon."'-" Intravenous nicardipine (NCR)4.5' 6) and 
prostaglandin E, (PGE,)''8.9' have been introduced in recent 
years to control blood pressure during clinical anesthesia, 
and have proved to be useful for deliberate hypotension. 
  NCR lowers blood pressure resulting from vasodilation 
due to inhibition of calcium influx into the vascular smooth 
muscle. NCR mainly dilates resistance vesseles and also 
has an effect to increase coronary blood flow.'°' PGE, 
exerts direct relaxing action on the vascular smooth muscle 
and causes hypotension. PGE, also has been shown to 
cause coronary vasodilation and reduction of both preload 
and afterload of the left ventricle.". 12. 13) 
 The blood flow to ischemic myocardium depends on 
coronary perfusion pressure, and it is risky to lower arterial 
pressure in the patients with ischemic heart disease."' 
Although NCR and PGE, are considered to be beneficial 
for the ischemic heart, it is not clear how these compounds 
affect the heart with critical coronary-artery stenosis14' 
when administered to lower arterial blood pressure rapidly 
during general anesthesia.
 The present study was designed to investigate the effects 
of NCR- and PGE,-induced hypotension on left ventricular 
myocardial function, and on coronary hemodynamics in the 
presence of partially obstructed left coronary circulation.
Materials and Methods. 
Surgical preparation 
Sixteen mongrel dogs of either sex, weighing 11.4 to 15.6 
(mean 13.1) kg were used in this study. Anesthesia was 
induced with 30mg/kg of sodium pentobarbital i. v., and 
maintained with continuous infusion of sodium pentobar-
bital, 1 mg/kg/min, pancuronium chloride, i. v. appropri-
ately, and inhalation of 50% N2O in O2. The animals were 
intubated with a cuffed endotracheal tube and ventilated 
mechanically with air at a tidal volume of 15ml/kg. End-
tidal CO, concentration was measured continuously with an 
infrared CO2 analyzer (Datex, Helsinki) and maintained at 
levels of 35-40mmHg by adjusting the respiratory rate. An 
infrared heating lamp and a circulating water blanket were 
used to maintain the esophageal temperature between 
37-38.5C. Arterial blood gas analysis and measurement of 
serum electrolytes were carried out frequently to maintain 
pH of 7.35 to 7.45, serum Na of 135 to 155mEq/1 and 
serum K of 3.7 to 5.3mEq/1. Active intervention was not 
necessary to maintain these ranges except for adjusting pH 
with 7% NaHCO3 solution in some animals. 
  In all dogs, catheters were inserted into the femoral vein, 
into the abdominal aorta via the left femoral artery (Fig. 1). 
Normal saline was administered at a rate of 4-6ml/kg/hr 
into the femoral vein into which NCR and PGE, were also 
administered. Intraarterial pressure was monitored via the 
abdominal aorta. The chest was opened through the sixth 
left intercostal space, and the heart was suspended in a 
pericardial cradle. Precalibrated electromagnetic flow 
probes (Nihon Kohden, Japan) of appropriate sizes to 
ensure a snug fit were placed around the ascending aorta, 
the left circumflex coronary artery (LCX) approximately 
1-2cm distal to its origin, and the left anterior descending 
coronary artery (LAD) distal to its first large diagonal
Fig. 1. Schematic diagram of the experimental preparation
branch. The flow probes were connected to flowmeters 
(Nihon Kohden, Japan). A catheter was inserted into the 
left ventricle via the cardiac apex to measure the left 
ventricular pressure. A damping device (Accudynamics 
Sorenson Research, Salt Lake City) was used to get an 
appropriate damping of the pressure wave. Myocardial 
blood flow was measured with the hydrogen gas clearance 
method using platinum tissue electrodes (200um in diam-
eter) at both the outer layers (2-3mm in depth) and the 
inner layers (8-9mm in depth). 
Experimental protocol 
At the end of the surgical preparation, at least 30min were 
allowed for stabilization. After control readings (presten-
osis value) had been obtained, a stenosis of LCX was 
induced using a stainless steel screw type mechanical 
occluder placed immediately distal to the flow probes. The 
stenosis was defined as the constriction necessary to reduce 
LCX blood flow by 20%. About 30min was allowed after 
inducing stenosis for the reactive hyperemia to disappear 
and for hemodynamic stabilization, and the second 
readings (basal value) were obtained. 
 Then the dogs were randomly divided into two groups to 
recieve NCR or PGE,. Both NCR and PGE, were dissolved 
in normal saline, and NCR was used as a 0.02% solution, 
PGE, as a 0.0025% solution. NCR and PGE, was infused at 
a dose which caused decrease in MAP to 80% of the basal 
value. After maintenance of stable MAP for 30min, the 
third readings (80% MAP value) were obtained. The dose 
of NCR or PGE, was then increased to cause decrease in 
MAP to 60% of the basal value. After maintenance of
stable MAP for 30min, the fourth readings (60% MAP 
value) were obtained. The hemodynamic data were calcu-
lated by the formula shown in Table 1.
Table 1. Hemodynamic Formulas
 -CI = CO/BSA 
 •TPR = MAP x 79.92/CO 
 •I/O RATIO = MBFI/MBFO 
 •OER = (Ca02-CcsO2)/Ca02 x 100 
 •LER = (LaA-LaCS)/LaA x 100 
ABBREVIATIONS 
CI: cardiac index CO: cardiac output 
BSA: = body surface area 0.112 x (weight:kg)' 
TPR: total peripheral resistance 
MBFI: myocardial blood flow through the inner layer 
MBFO: myocardial blood flow through the outer layer 
OER: myocardial oxygen extraction ratio 
Ca02: arterial oxygen content 
CcsO2: coronary sinus oxygen content 
LER: myocardial lactate extraction ratio 
LaA: arterial lactate content 
LaCS: coronary sinus lactate content
Statistics 
For statistical analysis, paired t-test was used for compar-
ison between the basal value and the pre-stenosis value and 
between 80%-MAP or 60%-MAP value and the basal 
value. Non-paired t-test was used for comparison between 
groups of NCR and PGE,. All results are expressed as 
mean ± SEM. A P value less than 0.05 was considered 
statistically significant.
Results 
The mean doses to maintain 80%- and 60%-MAP were 5.2 
± 0.54 and 15.6 ± 1.58,ug/kg/min for NCR, and 0.63 ± 
0.04 and 1.90 ± 0n l3,ug/kg/min for PGE,. 
  Heart rate, cardiac index, left ventricular dp/dt max 
showed no significant change at 80%- or 60%-MAP in 
either drug (Table 2 and 3). Total peripheral resistance 
exhibited significant decrease dose-dependently at 80%-
and 60%-MAP in both drugs. Left ventricular end-diastolic 
pressure showed a significant decrease at 80%- and 60%-
MAP in PGE,, but showed no change in NCR. The blood 
flow in the left anterior descending coronary artery (LADF), 
which was a non-stenosed vessel, showed no significant 
change at 80%- or 60%-MAP in either drug. Myocardial 
blood flow at the inner (MBFI) and outer layers (MBFO) of 
the left circumflex coronary artery stenosis region showed 
no significant change at 80%- or 60%-MAP in either drug. 
There was a significant increase in inner/outer blood flow 
(I/0) ratio at 60%-MAP in NCR (Fig. 2). Myocardial 
oxygen extraction ratio (OER) and Myocardial lactate 
extraction ratio (LER) showed no significant change at 
80%- or 60%-MAP in either drug (Fig. 3 and 4).
Table 2. Effects of Nicardipine-Induced Hypotension on Systemic and Coronary Hemodynamics (Mean ± SEM; N = 8)
                                                                       Stenosis 
        Variables Prestenosis 
                                                  Basal 80%-MAP 60%-MAP 
 HR (bpm) 143 ± 3 141 ± 2 140±4 136±5 
 MAP (mmHg) 134 ± 4 128 ± 5* 106 ± 6*,** 80 ± 6*,** 
 CI (1/min/m2) 2.57 ± 0.16 2.53 ± 0.15 2.74 ± 0.20 2.78 ± 0.13 
 LVdp/dtmax (mmHg/sec) 3600 ± 133 3314 ± 175* 3371 ± 175 2951 ± 305 
 LVEDP (mmHg) 3.38 ± 0.45 3.88 ± 0.55 3.50 ± 0.64 3.75 ± 0.69 
 TPR (dynes-sec/em') 7055 ± 470 6840 ± 476 5306 ± 505*,** 3854 ± 348*,** 
 LCXF (ml/min) 44.0 ± 2.9 33.8 ± 3.1* 33.0 ± 2.7* 31.8 ± 2.9* 
 LADF (ml/min) 11.6 ± 1.1 13.6 ± 1.0* 13.1 ± 1.5 13.6 ± 2.0 
 MBFI (ml/100g/min) 86.2 ± 2.6 78.2 ± 3.9* 83.7 ± 5.7 80.6 ± 10.4 
 MBFO (ml/100g/min) 70.5 ± 3.9 58.6 ± 5.0* 61.1 ± 6.7 55.0 ± 9.1 
 I/O ratio 1.23 ± 0.04 1.37 ± 0.07* 1.41 ± 0.05* 1.51 ± 0.05* 
 OER (%) 63.3 ± 6.5 63.0 ± 4.4 56.2 ± 5.3 55.1 ± 6.9 
 LER (%) 34.6 ± 7.2 25.7 ± 5.9 27.4 ± 4.1 23.7 ± 5.1 
* P < 0.05 vs pre-stenosis value, * * P < 0.05 vs basal value
Table 3. Effects of Prostaglandin E,-Induced Hypotension on Systemic and Coronary Hemodynamics (Mean ± SEM; N = 8)
                                                                       Stenosis 
        Variables Prestenosis 
                                                Basal 80%-MAP 60%-MAP 
 HR (bpm) 141 ± 2 141 ±2 144 ± 4 144 ± 4 
 MAP (mmHg) 141 ± 6 130 ± 7* 111 ± 6*,** 87 ± 4*,** 
 CI (1/min/m2) 2.51 ± 0.16 2.53 ± 0.17 2.77 ± 0.17* 2.72 ± 0.23 
 LVdp/dtmax (mmHg/see) 3656 ± 93 3456 ± 170 3455 ± 98 3279 ± 150* 
 LVEDP (mmHg) 3.38 ± 0.67 4.25 ± 0.85* 3.38 ± 0.83** 3.25 ± 0.69** 
 TPR (dynes-sec/em') 7264 ± 209 6664 ± 297* 5208 ± 246*,** 4264 ± 345*,** 
 LCXF (ml/min) 42.9 ± 2.9 34.0 ± 2.5* 32.5 ± 2.2* 29.0 ± 2.0*,** 
 LADF (ml/min) 10.5 ± 1.1 12.9 ± 1.1 13.8 ± 0.9* 12.4 ± 1.0* 
 MBFI (ml/lOOg/min) 86.9 ± 2.0 86.4 ± 4.9 89.2 ± 2.8 83.7 ± 4.6 
 MBFO (ml/100g/min) 67.3 ± 2.7 66.0 ± 4.0 65.5 ± 2.3 63.1 ± 2.3 
 I/O ratio 1.30 ± 0.07 1.32 ± 0.05 1.37 ± 0.04 1.33 ± 0.06 
 OER (%) 66.1 ± 2.7 69.0 ± 4.9 65.1 ± 1.7 65.3 ± 3.8 
 LER (%) 36.8 ± 4.1 25.1 ± 4.6* 22.8±3.5* 25.6 ± 5.2* 
* P < 0.05 vs pre-stenosis value, ** P < 0.05 vs basal value
Fig. 2. Effects of nicardipine- and prostaglandin E,-induced 
hypotension on the inner/outer layer (I/O) ratio of myocardial 
blood flow (mean ± SEM; n = 8 for each value) 
*P < 0.05 VS Pre-stenosis value, ***P < 0.05 between the groups
Fig. 3. Effects of nicardipine- and prostaglandin E,-induced 
hypotension on the myocardial oxygen extraction ratio (OER) 
(mean ± SEM; n = 8 for each value)
Fig. 4. Effects of nicardipine- and prostaglandin E,-induced 
hypotension on the myocardial lactate extraction ratio (LER) 
(mean ± SEM; n = 8 for each value) * P < 0.05 VS Pre-stenosis value
Discussion 
A model of critical coronary artery stenosis'°' was made in 
the present experiment. Under this condition, the coronary 
artery distal to stenosis was dilated maximally and the 
autoregulation was lost. Thus, the coronary blood flow 
would depend on the coronary perfusion pressure."' In-
deed, in the present experiment, the blood flow of the 
stenosed artery decreased in proportion as the arterial 
pressure lowered. It is known that the aggravation of 
myocardial oxygen demand-supply relationship develops 
initially at the inner leyers and that the cellular necrosis 
during ischemia begins from the inner layers."' In the 
normal heart, the inner layers of the ventricle have a higher 
blood flow per unit weight than the outer layers, and the 
oxygen consumption of the inner layers is also higher than 
that of the outer layers."' In the heart with coronary artery 
stenosis, the myocardial blood flow at the inner layers is 
characteristically underperfused due to the low coronary 
pressure caused by stenosis.'a' In the present experiment, 
there was no significant difference in the myocardial blood 
flow at the inner layers and myocardial blood flow at the 
outer layers at the stenosed area at 80%- or 60%-MAP in 
either NCR or PGE,. It has been reported that the I/O ratio 
in the left ventricle of dogs are between 1.0 to 1.3 in the 
absence of narrowed coronary artery."' in the persent 
results, the I/O ratio was more than 1.0 at 80%- and 
60%-MAP during both drugs, suggesting that there would 
be no insufficient perfusion in the inner layers of the 
ventricle.
 It is known that when myocardial oxygen demand in-
creases, the coronary artery blood flow also increases to 
cope with it, but myocardial oxygen extraction ratio does 
not change. In the present study, the myocardial oxygen 
extraction ratio did not change at 80%- or 60%-MAP 
during either drug, indicating that there might be coronary 
artery dilation, which were not due to an increase in the 
myocardial oxygen consumption. Myocardial lactate ex-
traction ratio is considered as an index for myocardial 
ischemia.20' It has been reported that the myocardial lactate 
extraction ratio less than 10% would indicate myocardial 
ischemia.21' In the present results, the myocardial lactate 
extraction ratio was more than 10% at both 80%- and 
60%-MAP during both drugs, and there was no significant 
difference between the two drugs. 
 Heart rate is an important factor to determine myocardial 
ischemic disorder,") and the local myocardial contractility 
might be effected when heart rate increases. In the present 
study, heart rate remained almost constant, and seemed not 
to play a role in the change of myocardial oxygen demand-
supply relationship. CI and LVdp/dt max showed no signif-
icant change at 80%- and 60%-MAP in either drug, indi-
cating that there was no myocardial depression during the 
each drug-induced hypotension. 
  In conclusion, the moderate hypotension induced by 
NCR or PGE, does not exert either myocardial depression 
or adverse effects on the myocardial oxygen supply-
demand relationship in the presence of a critical coronary 
stenosis.
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